Increased mean platelet volume after oestrogen replacement therapy

Annals of Clinical Biochemistry

Volumn 33, Issue 6, 1996, Pages 555-560

  Ranganath, L R ^a   Christofides, J ^a   Semple, M J ^a  

^a EPSOM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Hormone replacement therapy; Platelet membrane fatty acids

Indexed keywords

ARACHIDONIC ACID; ESTRADIOL; ESTROGEN; FOLLITROPIN; LEVONORGESTREL; LINOLEIC ACID; LUTEINIZING HORMONE;

ADULT; ARTICLE; CHROMATOGRAPHY; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; LUTEINIZING HORMONE BLOOD LEVEL; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE MEMBRANE; THROMBOCYTE VOLUME;

EQUIDAE;

EID: 0029966983     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329603300612     Document Type: Article

References (23)

1. Mashchak CA, Lobo RA, Dozono-Takano R, Eggena P, Nakamura RM, Brenner PF, et al. Comparison of pharmacodynamic properties of various oestrogen formulations. Am J Obstet Gynaecol 1982; 144: 511-8
2. Coope J, Thompson JM, Poller L. Effects of natural oestrogen replacement therapy on menopausal symptoms and blood clotting. BMJ, 1975; iv: 139
3. Notelovitz M, Greig HBW. The effect of natural oestrogen on coagulation. S Afr Med J 1975; 49: 101
4. Ahmed Y, Iddekinge BV, Paul C, Sullivan MH, Elder MG. Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol 1993; 100: 216-20
5. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Throm Res 1983; 32: 443-60
6. Jakubowski JA, Thompson CB, Vaillancourt R, Valeri CR, Deykin D. Arachidonic acid metabolism by platelets of differing size. Br J Haematol 1983; 53: 503
7. Martin JF, Bath PMW, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409-11
8. Hutton RA. Normal haemostasis. In: Hoffbrand AV, Lewis SM, ed. Postgraduate Haematology, London: Heinemann Professional, 1989: 560-97
9. Tygart SG, McRoyan DK, Spinnato JA, McRoyan CJ, Kitay DZ. Longitudinal study of platelet indices during normal pregnancy. Am J Obstet Gynecol 1986; 154: 883-7
10. Hunter WM, Bennie JG. Reduction of non-specific serum responses in human pituitary gonadotrophin radioimmunoassays. J Endocrin 1979; 80: 59-68
11. Barradas MA, Christofides JA, Jeremy JY, Mikhailidis DP, Fry DE, Dandona P. The effect of olive oil supplementation on human platelet function, serum cholesterol related variables and plasma fibrinogen concentration: a pilot study. Nutr Res 1990; 10: 403-11
12. Levin J, Bessman JD. The inverse relation between platelet volume and platelet number: Abnormalities in haematologic disease and evidence that platelet size does not correlate with platelet age. J Lab Clin Med 1983; 101: 295-307
13. Bessman JD, Williams LJ, Gilmer PR. Platelet size in health and haematologic disease. Am J Clin Pathol 1982; 78: 150-3
14. Kuhnz W, al-Yacoub G, Fuhrmeister A. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation. Contraception 1992; 46: 455-69
15. Ranganath LR, Christofides J, Wright JW, Marks V. Effect of hormone replacement therapy on platelet membrane fatty acid composition. J Endocrin 1996; 148: 207-12
16. Oates JA, Fitzgerald GA, Branch RA, Jackson EK, Knapp HR, Roberts LJ Jr. Clinical implications of prostacyclin and thromboxane A2 formation (first of two parts). N Engl J Med 1988; 319: 689-98
17. Wehmeier A, Scharf RE, Schneider W. Influence of splenectomy on platelet morphology and function. Klin Wochens 1990; 68: 847-52
18. Siegbahn A, Odlind V, Hedner U, Venge P. Coagulation and fibrinolysis during the normal menstrual cycle. Upsala J Med Sci 1989; 94: 137-52
19. Giles C. The platelet count and mean platelet volume. Br J Haematol 1981; 48: 31-7
20. Henriksson P. Oestrogen in patients with prostate cancer. An assessment of the risks and benefits. Drug Safety 1991; 6: 47-53
21. Thomson JM, Poller L, Bocaz JA, Barja P, Bonnar J, Daly L, et al. A multicentre study of coagulation and haemostatic variables during oral contraception; Variation with four formulations. Br J Obstet Gynaecol 1991; 98: 1117-28
22. Notelovitz M, Greig HB. Effect of natural oestrogen on coagulation [Letter]. BMJ 1974; 3: 171
23. Sporrong T, Mattson LA, Samsoe G, Stigendal L, Hellgren M. Haemostatic changes during continuous oestradiol-progestogen treatment of postmenopausal women. Br J Obstet Gynaecol 1990; 97: 939-44